Thermo Fisher Scientific extends partnership with Symphogen to support biopharma
Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments
Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments
Flowflex antigen test detects Covid-19, including the Omicron variant, in just 15 minutes with 98.8% accuracy
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
Collaboration with MTPC to discover novel hit compounds for multiple drug targets
The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control
New InterStim X system provides 10 to 15 years of battery life without the need to recharge
As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern
New biotechnology product aims to be world's fastest automatic sanitary solution
He will continue to lead business in LATAM and Asia regions in this new role
Subscribe To Our Newsletter & Stay Updated